홈 > 시장보고서 > 의약품 > 약물전달

시장보고서

상품코드

1375080

유럽의 의료용 경피흡수 패치 시장 예측 - 지역별 분석 : 유형, 용도 및 유통 채널별 분석

Europe Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel

발행일: 2023년 08월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 158 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유럽의 의료용 경피 흡수 패치 시장은 2023년 24억 3,409만 달러에서 2028년 30억 7,958만 달러로 성장할 것으로 예상되며, 2023년부터 2028년까지 4.8%의 CAGR을 나타낼 것으로 추정됩니다.

만성 질환의 유병률 증가로 유럽 의료용 경피흡수 패치 시장 성장 촉진

의료용 경피 흡수 패치는 심장병, 뇌졸중, 당뇨병, 암, 비만, 관절염과 같은 만성 질환을 앓고 있는 사람들에게 약물을 투여하는 데 사용됩니다.

심장 패치는 세포 이식 개선을 위한 우수한 플랫폼을 제공합니다. 예를 들어, 최근 개발된 혈관 신생 심장 패치는 허혈성 심장 손상 치료에 유망한 잠재력을 보여주었습니다. 니트로글리세린 경피 패치는 관상 동맥 질환 환자의 협심증(흉통) 에피소드를 예방하는 데 사용됩니다. 니트로글리세린은 혈관을 이완시켜 심장의 부담을 줄이고 산소의 필요성을 감소시킵니다. 그러나 이 패치는 이미 시작된 협심증 발작을 치료하는 데 사용할 수 없습니다.

리바스티그민 패치는 경증, 중등도, 중증 알츠하이머병에 동반된 치매(기억력 장애) 또는 파킨슨병에 동반된 경증에서 중등도의 치매를 치료하는 데 사용됩니다. 콜린에스테라아제 억제제인 리바스티그민과 도네페질은 용량 반응 관계를 보여 고용량일수록 더 높은 효과를 보입니다. 리바스티그민은 작고 친유성, 친수성 분자이기 때문에 화학적으로 경피투여에 적합합니다. 리바스티그민 부착제의 기본 기술은 눈에 띄지 않을 정도로 작고 얇은 외관에 기여합니다. 따라서 리바스티그민 점착제는 고용량의 효능을 빠르고 쉽게 이용할 수 있습니다.

따라서 만성 질환의 유병률 증가는 의료용 패치에 대한 수요를 촉진합니다.

유럽 의료용 경피흡수 패치 시장 개요

유럽의 의료용 경피흡수 패치 시장은 영국, 독일, 스페인, 이탈리아, 기타 유럽으로 구분되며, 2022년 유럽 의료용 경피흡수 패치 시장에서 가장 큰 점유율을 차지한 국가는 영국이었습니다. 만성 및 바이러스성 질환을 앓고 있는 환자 수 증가와 연구개발 활동의 활성화가 의료용 경피흡수 패치 시장을 견인하는 주요 요인으로 꼽힙니다. 또한, 만성 질환의 유병률 증가도 시장 확대에 영향을 미치고 있습니다.

2028년까지 유럽 의료용 경피흡수패치 시장 매출 및 예측(금액)

유럽 의료용 경피흡수 패치 시장 세분화

유럽의 의료용 경피 흡수 패치 시장은 유형, 용도, 유통 채널 및 국가별로 분류됩니다.

유형별로는 단층 약물 접착제, 다층 약물 접착제, 저수지, 증기 패치 및 매트릭스로 구분되며, 2023년에는 매트릭스 부문이 가장 큰 시장 점유율을 기록할 것으로 예상됩니다.

용도별로 유럽 의료용 경피흡수 패치 시장은 신경질환, 통증 관리, 니코틴 금연, 심혈관 질환, 호르몬 요법, 기타로 구분됩니다. 통증 관리 분야가 2023년 가장 큰 시장 점유율을 차지했습니다.

유럽 의료용 경피흡수 패치 시장은 유통 채널에 따라 병원 약국, 소매 약국, 온라인 약국으로 나뉩니다. 병원 약국 부문이 2023년 가장 큰 시장 점유율을 차지했습니다.

국가별로 유럽의 의료용 경피 흡수 패치 시장은 독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽으로 구분되며, 2023년 시장 점유율은 독일이 독점하고 있습니다.

Boehringer Ingelheim International GmbH, Endo International Inc, Kugo Pharmaceuticals, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, Viatris Inc 등이 이 지역의 의료용 경피흡수 패치 시장에서 활동하는 주요 기업입니다.

A cardiac patch provides an excellent platform for cell engraftment improvement. For example, a vascularized cardiac patch developed recently showed promising potential for treating ischemic heart injuries. Nitroglycerin transdermal patches are used to prevent angina (chest pain) episodes in people with coronary artery disease. It works by relaxing the blood vessels and reducing the stress on the heart, thereby lowering the need for oxygen. However, these patches cannot be used to treat angina attacks that have already begun.

Rivastigmine patch is used to treat dementia (memory loss) associated with mild, moderate, or severe Alzheimer's disease or mild-to-moderate dementia associated with Parkinson's disease. Rivastigmine and donepezil, which are cholinesterase inhibitors, exhibit a dose-response relationship, with higher doses of the drugs demonstrating greater efficacy. As a small, lipophilic, and hydrophilic molecule, rivastigmine is chemically well-suited for transdermal delivery. The technology underlying the rivastigmine patch contributes to its discreetly small and thin appearance. Thus, the rivastigmine patch enables quick and easy access to high-dose efficacy.

Therefore, the increasing prevalence of chronic diseases catalyzes the demand for medical patches.

Europe Transdermal Medical Patch Market Overview

The Europe transdermal medical patch market is segmented into the UK, Germany, Spain, Italy, and the Rest of Europe. In 2022, the UK held the largest share of the Europe transdermal medical patch market. The rising number of patients suffering from chronic conditions and viral diseases and increasing activities in research and development are the key factors propelling the market for transdermal medical patches. Also, the growing prevalence of chronic diseases are favoring market expansion.

Europe Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Europe Transdermal Medical Patch Market Segmentation

The Europe transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch and matrix. The matrix segment registered the largest market share in 2023.

Based on application, the Europe transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the Europe transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the Europe transdermal medical patch market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transdermal medical patch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Transdermal Medical Patch Market - by Type
- 1.3.2 Europe Transdermal Medical Patch Market - by Application
- 1.3.3 Europe Transdermal Medical Patch Market - by Distribution Channel
- 1.3.4 Europe Transdermal Medical Patch Market - by Country

2. Transdermal Medical Patch Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Transdermal Medical Patch Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Transdermal Medical Patch Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Consumption of Tobacco
5.2 Market Restraints
- 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
5.3 Market Opportunities
- 5.3.1 Increasing Strategic Initiatives
5.4 Future Trends
- 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
5.5 Impact analysis

6. Transdermal Medical Patch Market - Europe Analysis

6.1 Europe Transdermal Medical Patch Market Revenue Forecast and Analysis

7. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
7.3 Single-Layer Drug In-Adhesive
- 7.3.1 Overview
- 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multi-Layer Drug In-Adhesive
- 7.4.1 Overview
- 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Reservoir
- 7.5.1 Overview
- 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Vapor Patch
- 7.6.1 Overview
- 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Matrix
- 7.7.1 Overview
- 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
8.3 Neurologic Conditions
- 8.3.1 Overview
- 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Pain Management
- 8.4.1 Overview
- 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Nicotine Cessation
- 8.5.1 Overview
- 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiovascular Disorders
- 8.6.1 Overview
- 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Hormonal Therapy
- 8.7.1 Overview
- 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels

9.1 Overview
9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Europe: Transdermal Medical Patch Market
- 10.1.1 Overview
- 10.1.2 Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 UK: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 UK: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 UK: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.1.4 UK: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.1.5 UK: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.2 Germany: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Germany: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Germany: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Germany: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Germany: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.3 France: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 France: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 France: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.3.4 France: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.3.5 France: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.4 Spain: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Spain: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Spain: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.4.4 Spain: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.4.5 Spain: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.5 Italy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Italy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.3 Italy: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.5.4 Italy: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.5.5 Italy: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.6 Rest of Europe: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview

12. Company Profiles

12.1 Hisamitsu Pharmaceutical Co Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Medline Industries LP
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Johnson & Johnson
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Novartis AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 UCB SA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Viatris Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Endo Pharmaceuticals Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 3,450

￦ 4,895,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,450

￦ 6,314,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450

￦ 7,734,000

※ 부가세 별도

유럽의 의료용 경피흡수 패치 시장 예측 - 지역별 분석 : 유형, 용도 및 유통 채널별 분석

Europe Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel

목차

제1장 서론

제2장 의료용 경피 흡수 패치 시장 - 요점

제3장 조사 방법

제4장 유럽의 의료용 경피 흡수 패치 시장 - 시장 구도

제5장 유럽의 의료용 경피 흡수 패치 시장 : 주요 시장 역학

제6장 유럽의 의료용 경피 흡수 패치 시장 : 유럽 분석

제7장 유럽의 의료용 경피 흡수 패치 시장 - 2028년까지 매출과 예측-유형별

제8장 유럽의 의료용 경피 흡수 패치 시장 : 용도별 매출과 2028년까지 예측

제9장 유럽의 의료용 경피 흡수 패치 시장 : 2028년까지 매출과 예측 : 유통 채널별

제10장 의료용 경피 흡수 패치 시장 : 2028년까지 매출과 예측 : 국가별 분석

제11장 업계 상황

제12장 기업 개요

제13장 부록